Secora Michael — SEC insider filings
SEC reporting owner CIK 1855980. 34 insider filings on record with FilingPulse; latest filed 2026-10-19.
Transaction summary — filings shown
Covers all 34 filings on record, filed 2021-04-22 to 2026-10-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 39 legs across 17 filings — 728,124 shares, $6,399,417 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 107.
- Largest priced transaction: sale of 24,500 shares @ $13.62 ($333,778) in RECURSION PHARMACEUTICALS, INC., filed 2023-07-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 31 | — | 39 legs · 728,124 sh · $6,399,417 | 103 |
| Iambic Therapeutics, Inc. (IAM) | CFO & Chief Corp Dev Ofcr | 3 | — | — | 4 |
Insider filings — Secora Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-19 | 4 | Iambic Therapeutics, Inc. (IAM) | Conversion (C): 61,342 · Conversion (C): 61,342 (derivative) @ $0 | EDGAR |
| 2026-10-16 | 4 | Iambic Therapeutics, Inc. (IAM) | Grant/award (A): 28,400 @ $0 · Grant/award (A): 170,300 (derivative) @ $0 | EDGAR |
| 2026-10-14 | 3 | Iambic Therapeutics, Inc. (IAM) | Holdings only — no transactions reported | EDGAR |
| 2024-11-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 11,937 @ $6.17 | EDGAR |
| 2024-11-14 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $7.64 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $7.66 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-10-10 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.32 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.36 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.17 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.32 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 11,962 @ $6.69 | EDGAR |
| 2024-08-15 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.35 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.35 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-07-11 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $7.32 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $7.24 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $9.32 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $9.27 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 11,962 @ $10.01 | EDGAR |
| 2024-04-18 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $7.67 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 23,124 @ $7.58 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2024-03-14 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $10.46 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $11.03 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 7,172 @ $12.43 | EDGAR |
| 2024-02-15 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $9.86 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 23,933 @ $10.43 · Sale (S): 1,067 @ $10.98 · Option exercise (M): 37,500 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-13 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 8,659 @ $0 · Grant/award (A): 174,190 @ $0 · Tax withholding (F): 2,512 @ $10.09 · Grant/award (A): 348,380 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $10.45 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $10.25 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2023-12-14 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $7.39 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $7.59 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2023-11-16 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $6.32 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 20,300 @ $7.25 · Sale (S): 4,700 @ $7.62 · Tax withholding (F): 7,172 @ $7.18 · +2 more | EDGAR |
| 2023-10-12 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $7.07 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $6.85 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2023-09-14 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $8.43 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $8.69 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2023-08-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 4,727 @ $9.19 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $9.27 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $8.90 · Option exercise (M): 37,500 (derivative) @ $0 · +1 more | EDGAR |
| 2023-07-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 24,500 @ $13.62 · Sale (S): 500 @ $14.05 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 1,991 @ $14.36 · Sale (S): 13,150 @ $15.36 · +3 more | EDGAR |
| 2023-06-15 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $9.93 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $10.07 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2023-05-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 4,760 @ $5.60 | EDGAR |
| 2023-04-28 | 4/A | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 58,342 @ $0 · Grant/award (A): 1,957 @ $0 · Tax withholding (F): 678 @ $11.40 | EDGAR |
| 2023-02-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 1,258 @ $8.44 | EDGAR |
| 2023-02-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 202,428 @ $0 · Grant/award (A): 7,735 @ $0 · Tax withholding (F): 2,669 @ $8.55 · Grant/award (A): 404,857 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 1,065 @ $11.86 | EDGAR |
| 2022-08-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 1,065 @ $12.96 | EDGAR |
| 2022-05-18 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 1,069 @ $5.67 | EDGAR |
| 2022-02-08 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 58,342 @ $0 · Grant/award (A): 1,957 @ $0 · Tax withholding (F): 678 @ $11.40 · Grant/award (A): 116,684 (derivative) @ $0 · Grant/award (A): 3,914 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 149,077 · Other (J): 528,762 · Other (J): 528,762 · Conversion (C): 149,077 (derivative) @ $0 · Conversion (C): 820,313 (derivative) @ $0 · Conversion (C): 1,500,000 (derivative) @ $0 · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-04-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1855980 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs